Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.
We send one confirmation email first. Only emails about QUIT, unsubscribe in one click. Privacy
Quoted word for word from the company's press releases filed with the SEC. Timing is the company's own guidance, not a BioRadar estimate.
Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.
QUIT holds $201.5M in cash and short-term investments and burns about $11M/quarter from operations, an estimated runway of 54.9 months at that rate (BioRadar estimate, not company guidance).
Dilution pressure: 45 · Elevated
Recent financing filings on SEC EDGAR:
Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when QUIT files for a raise →
| Holder | Type | Shares | % of shares | As of |
|---|---|---|---|---|
| venBio Global Strategic Fund V, L.P. | 5%+ holder (13D) | 10,737,317 | 9.76% | 2026-04-15 |
| Logos Global Management LP | Institution (13G, 5%+) | 10,538,440 | 9.58% | 2026-05-11 |
| Paradigm BioCapital Advisors LP | 5%+ holder (13G) | 9,903,712 | 9.00% | 2026-04-17 |
| Franklin Resources, Inc. | Institution (13G, 5%+) | 8,878,942 | 8.07% | 2026-06-30 |
| TPG GP A, LLC 10% owner |
Insider | 6,877,580 | 6.25% | 2026-04-17 |
| Frazier Life Sciences Public Fund, L.P. | 5%+ holder (13G) | 6,625,788 | 6.02% | 2026-04-17 |
| JANUS HENDERSON GROUP Ltd. | Institution (13G, 5%+) | 5,502,064 | 5.00% | 2026-06-30 |
| Venrock Healthcare Capital Partners III, | 5%+ holder (13G) | 5,502,064 | 5.00% | 2026-04-17 |
| Vivo Opportunity, LLC | 5%+ holder (13G) | 5,305,640 | 4.82% | 2026-07-06 |
| BlackRock, Inc. | Institution (13G, 5%+) | 5,271,391 | 4.79% | 2026-06-30 |
| Thomas Braxton King Director |
Insider | 315,142 | 0.29% | 2025-09-04 |
| Richard Alistair Stewart Director · +686,700 options |
Insider | 209,490 | 0.19% | 2026-08-19 |
Share count 110,034,457 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.
The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for QUIT and every other ticker you follow. Card required, cancel anytime.
Start 7-day free trial →